Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine U300 vs U100 in Inpatient T2D
NCT03013985Phase 4Completed
- Sponsor
- Emory University
- Start
- May 2017
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Emory University. Started May 2017; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03013985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03013985.